Drug intelligence / Profile preview

Xuanling Yinhuang Formula

Development stage: Unknown
Lead developer: Beijing Ditan Hospital
Administration: Oral

Overview

Xuanling Yinhuang Formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by Beijing Ditan Hospital, Capital Medical University, for the treatment of central nervous system infections. It is primarily used as an adjunctive therapy for adult patients with viral encephalitis and viral meningitis, particularly those presenting with specific TCM syndromes such as phlegm-heat or damp-heat affecting the brain. In clinical trials, it is often evaluated in combination with Angong Niuhuang Bolus alongside standard Western antiviral and supportive treatments. The formula aims to clear heat, resolve phlegm, and detoxify the system to reduce neurological symptoms and improve recovery outcomes.

Other names: Xuanling Yinhuang Fang

Beyond the preview

Go deeper on Xuanling Yinhuang Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xuanling Yinhuang Formula.

Explore the full profile